5-(Thiophen-2-yl)isoxazoles as novel anti-breast cancer agents targeting ERα: synthesis, in vitro biological evaluation, in silico studies, and molecular dynamics simulation
Year: 2025
Type: article
Abstract: A new series of 5-(thiophen-2-yl)isoxazoles has been designed, synthesized, and subjected to in vitro anti-cancer screening, which revealed a new molecule, TTI-6, to be the best anti-breast cancer agent (IC 50 = 1.91 μM against MCF-7) among others.
Source: RSC Medicinal Chemistry
DOI: 10.1039/d5md00339c
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: hybrid
Funders: Department of Science and Technology, Ministry of Science and Technology, India, Indian Council of Medical Research, Council of Scientific and Industrial Research, India, Birla Institute of Technology and Science, Pilani, Science and Engineering Research Board, National Institute of Mental Health
OpenAlex ID: W4411616508
